Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne J Gonzales-Luna

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2019
Letter to the EditorAnne J Gonzales-Luna, Travis J Carlson
The Journal of Antimicrobial Chemotherapy|July 23, 2020
Utilizing antibiotics to prevent Clostridioides difficile infection: does exposure to a risk factor decrease risk? A systematic reviewTravis J Carlson, Anne J Gonzales-Luna
SAGE Open Medicine|October 10, 2024
Systematic review of the orally administered microbiome therapeutic, fecal microbiota spores, live-brpk, to prevent recurrence of <i>Clostridioides difficile</i> infection in adultsKerry LaPlante, Robert Stevens, Anne J Gonzales-Luna
Seminars in Respiratory and Critical Care Medicine|February 16, 2022
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening InfectionTravis J Carlson, Anne J Gonzales-Luna, Kevin W Garey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2023
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection RecurrenceAnne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Gut Microbes|June 15, 2023
Gut microbiota changes associated with <i>Clostridioides difficile</i> infection and its various treatment strategiesAnne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Drugs|January 16, 2023
Emerging Options for the Prevention and Management of Clostridioides difficile InfectionAnne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Current Opinion in Gastroenterology|November 24, 2020
Recent developments in antimicrobial therapy for gastrointestinal infectionsTravis J Carlson, Anne J Gonzales-Luna, Kevin W Garey
Journal of the Pediatric Infectious Diseases Society|November 18, 2021
Antibiotic Therapies for Clostridioides difficile Infection in ChildrenAnne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Antibiotics (Basel, Switzerland)|September 28, 2023
The Significance of Bayesian Pharmacokinetics in Dosing for Critically Ill Patients: A Primer for Clinicians Using Vancomycin as an ExampleFaris S Alnezary, Masaad Saeed Almutairi, Anne J Gonzales-Luna, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2019
Letter to the EditorAnne J Gonzales-Luna, Travis J Carlson
The Journal of Antimicrobial Chemotherapy|July 23, 2020
Utilizing antibiotics to prevent Clostridioides difficile infection: does exposure to a risk factor decrease risk? A systematic reviewTravis J Carlson, Anne J Gonzales-Luna
SAGE Open Medicine|October 10, 2024
Systematic review of the orally administered microbiome therapeutic, fecal microbiota spores, live-brpk, to prevent recurrence of <i>Clostridioides difficile</i> infection in adultsKerry LaPlante, Robert Stevens, Anne J Gonzales-Luna
Seminars in Respiratory and Critical Care Medicine|February 16, 2022
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening InfectionTravis J Carlson, Anne J Gonzales-Luna, Kevin W Garey
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2023
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection RecurrenceAnne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Gut Microbes|June 15, 2023
Gut microbiota changes associated with <i>Clostridioides difficile</i> infection and its various treatment strategiesAnne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Drugs|January 16, 2023
Emerging Options for the Prevention and Management of Clostridioides difficile InfectionAnne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Current Opinion in Gastroenterology|November 24, 2020
Recent developments in antimicrobial therapy for gastrointestinal infectionsTravis J Carlson, Anne J Gonzales-Luna, Kevin W Garey
Journal of the Pediatric Infectious Diseases Society|November 18, 2021
Antibiotic Therapies for Clostridioides difficile Infection in ChildrenAnne J Gonzales-Luna, Travis J Carlson, Kevin W Garey
Antibiotics (Basel, Switzerland)|September 28, 2023
The Significance of Bayesian Pharmacokinetics in Dosing for Critically Ill Patients: A Primer for Clinicians Using Vancomycin as an ExampleFaris S Alnezary, Masaad Saeed Almutairi, Anne J Gonzales-Luna, et al.
Pageof 6